Is elevated methylmalonic acid a marker of functional vitamin B12 deficiency?

An objective evaluation of the evidence confirms that elevated methylmalonic acid (MMA) is a sensitive and validated biomarker for functional, tissue-level vitamin B12 deficiency. While total serum B12 measures circulating cobalamin—which may remain within normal limits despite intracellular depletion—MMA directly reflects cellular metabolic block.

Clinical and diagnostic evidence

• High Diagnostic Sensitivity: Serum or plasma MMA possesses a sensitivity greater than 95% in identifying functional tissue-level vitamin B12 deficiency. It is particularly valuable when serum B12 levels are in the borderline range (180–350 pg/mL), where up to 30% of patients may suffer from intracellular deficiency.
• Established Diagnostic Cutoffs: A serum/plasma MMA level exceeding 0.3 to 0.4 µmol/L is generally indicative of biochemical deficiency. Higher thresholds (e.g., above 0.75 µmol/L) provide greater specificity for clinically significant deficiency, particularly in patients presenting with unexplained neurological symptoms.

Cellular mechanisms

• Enzymatic Blockade: Within the mitochondria, adenosylcobalamin (an active form of vitamin B12) acts as an essential cofactor for the enzyme methylmalonyl-CoA mutase.
• Metabolic Accumulation: When intracellular cobalamin is depleted, methylmalonyl-CoA mutase activity is impaired. This blocks the conversion of methylmalonyl-CoA to succinyl-CoA, leading to an upstream accumulation of methylmalonic acid that leaks into the extracellular fluid and circulation.

Confounding factors and limitations

• Renal Impairment: MMA is cleared by the kidneys. Decreased glomerular filtration rate (eGFR < 60 mL/min/1.73m²), which is highly common in older adults, reduces renal clearance and elevates plasma MMA levels independently of vitamin B12 status.
• Urinary Adjustments: To circumvent the confounding effect of renal decline, measuring the urinary MMA-to-creatinine ratio (uMMA/C) is highly effective. A threshold of 1.45 µmol/mmol creatinine indicates functional B12 deficiency with high specificity, bypassing the impact of reduced kidney function.
• Bacterial Overgrowth: Small bowel bacterial overgrowth can lead to increased synthesis of propionate and methylmalonate by intestinal microflora, potentially elevating systemic MMA levels in the absence of true B12 deficiency.

Bottom line

Elevated methylmalonic acid is a premier functional marker of tissue-level vitamin B12 deficiency, crucial for diagnosing subclinical deficiency when serum B12 levels are borderline. However, in older adults or patients with suspected renal impairment, plasma MMA values must be interpreted cautiously, and a urinary MMA-to-creatinine ratio should be considered to rule out false positives.